These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4570233)

  • 1. Some speculations concerning a possible biochemical basis of minimal brain dysfunction.
    Wender PH
    Ann N Y Acad Sci; 1973 Feb; 205():18-28. PubMed ID: 4570233
    [No Abstract]   [Full Text] [Related]  

  • 2. The minimal brain dysfunction syndrome in children. I. The syndrome and its relevance for psychiatry. II. A psychological and biochemical model for the syndrome.
    Wender PH
    J Nerv Ment Dis; 1972 Jul; 155(1):55-71. PubMed ID: 4402515
    [No Abstract]   [Full Text] [Related]  

  • 3. How amphetamine acts in minimal brain dysfunction.
    Snyder SH; Meyerhoff JL
    Ann N Y Acad Sci; 1973 Feb; 205():310-20. PubMed ID: 4570236
    [No Abstract]   [Full Text] [Related]  

  • 4. Some speculations concerning a possible biochemical basis of minimal brain dysfunction.
    Wender PH
    Life Sci; 1974 May; 14(9):1605-21. PubMed ID: 4601632
    [No Abstract]   [Full Text] [Related]  

  • 5. The biochemical basis of minimal brain dysfunction.
    Shaywitz SE; Cohen DJ; Shaywitz BA
    J Pediatr; 1978 Feb; 92(2):179-87. PubMed ID: 340625
    [No Abstract]   [Full Text] [Related]  

  • 6. Gilles de la Tourette's disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient.
    Meyerhoff JL; Snyder SH
    Psychopharmacologia; 1973; 29(3):211-20. PubMed ID: 4512896
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction.
    Shaywitz BA; Yager RD; Klopper JH
    Science; 1976 Jan; 191(4224):305-8. PubMed ID: 942800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary monoamine metabolites in children with minimal brain dysfunction.
    Wender PH; Epstein RS; Kopin IJ; Gordon EK
    Am J Psychiatry; 1971 Apr; 127(10):1411-5. PubMed ID: 5549938
    [No Abstract]   [Full Text] [Related]  

  • 9. Biogenic amines and psychiatry.
    Aust N Z J Psychiatry; 1971 Mar; 5(1):4-9. PubMed ID: 4946453
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurochemical correlates of attention deficit disorder.
    Raskin LA; Shaywitz SE; Shaywitz BA; Anderson GM; Cohen DJ
    Pediatr Clin North Am; 1984 Apr; 31(2):387-96. PubMed ID: 6728523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.
    Frank MJ; Santamaria A; O'Reilly RC; Willcutt E
    Neuropsychopharmacology; 2007 Jul; 32(7):1583-99. PubMed ID: 17164816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder.
    Yan TC; Hunt SP; Stanford SC
    Neuropharmacology; 2009 Dec; 57(7-8):627-35. PubMed ID: 19748515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Some speculations concerning a possible biochemical basis of minimal brain dysfunction.
    Wender PH
    Psychopharmacol Bull; 1974 Oct; 10(4):35-6. PubMed ID: 4471620
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tourette syndrome. Genetics, neuroanatomy and neurotransmitters].
    Debes NM; Skov L; Hjalgrim H
    Ugeskr Laeger; 2008 Aug; 170(35):2695-700. PubMed ID: 18761860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal brain dysfunction in children. Diagnosis and management.
    Wender PH
    Pediatr Clin North Am; 1973 Feb; 20(1):187-202. PubMed ID: 4581984
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
    Airaksinen E; Airaksinen MM
    Duodecim; 2003; 119(16):1553-62. PubMed ID: 14535028
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetics of childhood disorders: XXIII. ADHD, Part 7: The serotonin system.
    Quist JF; Kennedy JL
    J Am Acad Child Adolesc Psychiatry; 2001 Feb; 40(2):253-6. PubMed ID: 11211376
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural life history of children with minimal brain dysfunction.
    Denhoff E
    Ann N Y Acad Sci; 1973 Feb; 205():188-205. PubMed ID: 4120338
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.
    Rastmanesh R
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):149-57. PubMed ID: 21432601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.